Peters’s anomaly. A clinical case presentation
Journal Title: Revista Información Científica - Year 2018, Vol 97, Issue 2
Abstract
It described a case with anomaly of Peters, congenital defect of the cornea that appears of way generally sporadic and of etiology even uncertain. It does reference to his forms of presentation and to the possible treatments being the darkest prognosis when it accompanies of systemic manifestations. It explained how the diagnostic was reached. It is essentially clinical, letting some final considerations.
Authors and Affiliations
Annia Rodríguez Cambas, Uver Matos López, Marcelina Francisco Domingos, Maidolis Tirado Soler
Keywords
Related Articles
- EP ID EP441031
- DOI -
- Views 38
- Downloads 0
Delayed hemolytic transfusion reaction by anti-E alloantibody
We present the case of a 47-year-old woman, blood group O Rh D positive, G4P2A2, with no transfusion history, which required surgical intervention due to bleeding uterine fibroma. The pretransfusional tests were compatib...
Diagnosis of aspects and environmental impacts in the School of Dentistry of Havana
Introduction: Stomatology faculties have a predominant role in environmental management for their general performance, innovation and sustainable development. Objective: to diagnose the aspects and associated environment...
Parotidectomy 1992-2013 experience
It was carried out a descriptive study of the 97 patients assisted in the consultation of maxillofacial surgery of the Educational General Hospital Dr. Octavio de la Concepción y de la Pedraja, with tumors of the parotid...
Behavior of respiratory sounds in children less than five years of Sancti Spíritus
Introduction: respiratory sounds in preschool children are the main causes of morbidity treated in allergy clinics and represent a significant number of hospital admissions. Objective: to characterize the behavior of whe...
Diagnostic, therapeutic and prognostic implications of the BRAF V600E mutation in cutaneous melanomas
Introduction: Melanoma accounts for 4% of all malignant skin tumors, but is responsible for 80% of cancer deaths in this site. The emergence of therapies directed against the BRAF mutation has changed the prognosis, henc...